The archetypal episode, "Psychedelic Novelty - Before it was Cool," introduces the company's proprietary molecule MEAI
VANCOUVER, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” oregon the "company"), a biotech institution focused connected find and improvement of caller psychedelic-derived therapeutics to lick large undertreated wellness problems, is featured successful "Psychedelics Tonight", a caller amusement exploring the life-altering benefits of psychedelic medicines, which is streaming connected ALTRD.TV, a starring alternate contented TV network.
Now disposable for watching, the 3rd occurrence of the show, "Psychedelic Novelty - Before it was Cool", introduces Clearmind’s proprietary molecule MEAI, the subject down it, its mechanics of enactment and the imaginable to assistance radical suffering from intoxicant usage disorder. The 4th episode, besides featuring MEAI, "Novel Medicines- Undiscovered Psychedelics" airs connected Oct 17 connected the channel, which is disposable connected iOS app, Apple TV, Google TV, Google Play app and Ruko.
Psychedelics Tonight is simply a amusement astir paradigm-shifting ideas relating to the powerfulness and imaginable of psychedelics to payment people. The amusement was created by Kyle Buller and Joe Moore, who are besides the co-founders of Psychedelics Today. The Company participated successful accumulation costs for these 2 episodes of the show.
About Clearmind Medicine Inc.
Clearmind is simply a psychedelic pharmaceutical biotech institution focused connected the find and improvement of caller psychedelic-derived therapeutics to lick wide and underserved wellness problems, including intoxicant usage disorder. Its superior nonsubjective is to probe and make psychedelic-based compounds and effort to commercialize them arsenic regulated medicines, foods oregon supplements.
The Company’s intelligence portfolio presently consists of 7 patent families. The Company intends to question further patents for its compounds whenever warranted and volition stay opportunistic regarding the acquisition of further intelligence spot to physique its portfolio.
Shares of Clearmind are listed for trading connected the Canadian Securities Exchange nether the awesome "CMND", the Frankfurt Stock Exchange nether the awesome “CWYO” and connected the OTC Markets nether the awesome "CMNDF".
For further information, delight contact:
Investor Relations,
Email: invest@clearmindmedicine.com
Telephone: (604) 260-1566
General Inquiries,
Info@Clearmindmedicine.com
FORWARD-LOOKING STATEMENTS:
This quality merchandise whitethorn incorporate forward-looking statements and accusation based connected existent expectations. These statements should not beryllium work arsenic guarantees of aboriginal show oregon results. Such statements impact known and chartless risks, uncertainties and different factors that whitethorn origin existent results, show oregon achievements to beryllium materially antithetic from those implied by specified statements. Such statements see submission of the applicable documentation wrong the required timeframe to the restitution of the applicable regulators and raising capable financing to implicit the Company's concern strategy. There is nary certainty that immoderate of these events volition occur. Although specified statements are based connected management's tenable assumptions, determination tin beryllium nary assurance that specified assumptions volition beryllium to beryllium correct. We presume nary work to update oregon revise them to bespeak caller events oregon circumstances.
Investing into early-stage companies inherently carries a precocious grade of risk, and concern into securities of the Company shall beryllium considered highly speculative.
This property merchandise shall not represent an connection to merchantability oregon the solicitation of an connection to buy, nor shall determination beryllium immoderate merchantability of the securities successful immoderate state successful which specified offer, solicitation oregon merchantability would beryllium unlawful. The securities issued, oregon to beryllium issued, nether the Private Placement person not been, and volition not be, registered nether the United States Securities Act of 1933, arsenic amended, and whitethorn not beryllium offered oregon sold successful the United States absent registration oregon an applicable exemption from registration requirements.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that word is defined successful the policies of the CSE) accepts work for the adequacy oregon accuracy of this release.
English (US)